This is a double-blinded, controlled, randomized clinical trial (RCT) to establish the safety
and efficacy of a non-invasive neuromodulation device for treating symptoms associated with
Up to 218 participants will enter the double-blinded, controlled, randomized clinical trial
(RCT) and will self-administer treatments twice daily in the home setting over a period of 12
weeks following a 4 week baseline period. The RCT will have 6 study visits: 3 visits at the
study center and 3 visits completed in the participant's home by video call.
Parkinson Disease, Parkinson's Disease and Parkinsonism
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.